⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17501933 | 0.70 | — | — | |
| SCHEMBL1400977 | 0.64 | — | — | |
| SCHEMBL1522040 | 0.64 | — | — | |
| SCHEMBL11402652 | 0.64 | — | — | |
| SCHEMBL1071912 | 0.60 | — | — | |
| SCHEMBL16705227 | 0.57 | — | — | |
| SCHEMBL1400981 | 0.56 | — | — | |
| SCHEMBL17581115 | 0.55 | — | — | |
| SCHEMBL13461879 | 0.54 | — | — | |
| SCHEMBL2247172 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3988100-A1 | ADENOSINE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR STEREOISOMERIDE THEREOF, AND USE | Academy Of Military Medical Sciences (CN) | 2022-04-27 | — | — | EP | claimed |
| CN-114025763-A | Adenosine compound, pharmaceutically acceptable salt or stereoisomer thereof and application | 中国人民解放军军事科学院军事医学研究院 | 2022-02-08 | — | — | CN | claimed |
| WO-2020253866-A1 | ADENOSINE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR STEREOISOMERIDE THEREOF, AND USE | 中国人民解放军军事科学院军事医学研究院 | 2020-12-24 | — | — | WO | claimed |
| CN-114025763-B | Adenosine compound, pharmaceutically acceptable salt or stereoisomer thereof and application | 中国人民解放军军事科学院军事医学研究院 | 2023-09-12 | — | — | CN | disclosed |
| EP-3988100-A1 | ADENOSINE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR STEREOISOMERIDE THEREOF, AND USE | Academy Of Military Medical Sciences (CN) | 2022-04-27 | — | — | EP | disclosed |
| CN-114025763-A | Adenosine compound, pharmaceutically acceptable salt or stereoisomer thereof and application | 中国人民解放军军事科学院军事医学研究院 | 2022-02-08 | — | — | CN | disclosed |
| WO-2020253866-A1 | ADENOSINE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR STEREOISOMERIDE THEREOF, AND USE | 中国人民解放军军事科学院军事医学研究院 | 2020-12-24 | — | — | WO | disclosed |